Time course of conjunctival hyperemia induced by omidenepag isopropyl ophthalmic solution 0.002%: a pilot, comparative study versus ripasudil 0.4.

Etsuko TeraoShunsuke NakakuraYasuko FujisawaYuki NagataKanae UedaYui KobayashiSatomi OogiSaki DoteMiku ShiraishiHitoshi TabuchiTsuyoshi YonedaAtsuki FukushimaRyo AsaokaYoshiaki Kiuchi

Published in: BMJ open ophthalmology (2020)

Conjunctival hyperemia induced by omidenepag gradually peaks to moderate severity, though weaker compared with that induced by ripasudil 0.4%, and subsides relatively quickly.

Keyphrases

high intensity
randomized controlled trial
clinical trial